Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 226, Issue 10, Pages 2586-2594Publisher
WILEY
DOI: 10.1002/jcp.22604
Keywords
-
Categories
Funding
- National Basic Research Program of China (973 Program) [2007CB512000, 2007CB512006]
- National Natural Science Foundation of PR China [30900575, 30971252]
- Initiative Scientific Research Foundation for Postdoctor Back to Heilongjiang Province [LBH-Q09062]
- Foundation of Key Laboratory of Bio-pharmaceutical-engineering (Harbin Medical University), Ministry of Education [2010-01]
Ask authors/readers for more resources
A lot of evidence indicates that cardiac fibroblasts are essential for maintaining the structure and function of heart. The present study examined whether TGFBR3 (transforming growth factor type III receptor, also known as betaglycan) could prevent hypoxia-induced injury in neonatal mice cardiac fibroblasts, if so, its possible molecular targets. MTT, electron microscopy and TUNEL assay were used to identify cell viability and apoptosis in neonatal mice cardiac fibroblasts. Results showed that hypoxia for 24 h markedly reduce cell viability by 49.8 +/- 8.9%, largely via apoptosis. However, hypoxia-induced apoptosis in cardiac fibroblasts were almost completely prevented by overexpression of TGFBR3. In the present study, hypoxia also induced TGF-beta 1, p-Smad2/3 expression, TGFBR1-TGFBR2 complex formation and collagen production in cardiac fibroblasts, which were attenuated substantially by TGFBR3 overexpression. TGFBR3 also reversed Bax up-regulation, Bcl-2 down-regulation and Caspase-3 activation induced by hypoxia in cardiac fibroblasts. Hypoxia or TGF-beta 1 itself triggered an increase of [Ca2+](i) in cardiac fibroblasts, which were both inhibited by TGFBR3 overexpression. Taken together, our results indicate that TGFBR3 may act as a protective factor in apoptotic process of cardiac fibroblasts by negative regulation of TGF-beta signaling and represent a potential therapeutic target for heart remodeling after hypoxia injury. J. Cell. Physiol. 226: 2586-2594, 2011. (C) 2010 Wiley-Liss, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available